PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

GaN-based electron beam technology from Nagoya University startup poised to overcome critical semiconductor manufacturing challenges at KIOXIA

New platform for semiconductor inspection and metrology developed through joint research by Photo electron Soul and Nagoya University begins validation at KIOXIA Iwate

2025-09-01
(Press-News.org) NAGOYA, Japan — In late September 2025, KIOXIA Iwate Corporation (Koichiro Shibayama CEO) will begin evaluating a GaN-based e-beam technology developed through joint research between Photo electron Soul Inc. (PeS; Takayuki Suzuki CEO), a Nagoya University startup, and the Amano–Honda Laboratory at Nagoya University.

PeS has developed a next-generation electron gun specialized for GaN (gallium nitride) photocathodes and has demonstrated its effectiveness for semiconductor inspection and metrology (I&M), enabling electron microscopy of nanoscale transistors and high-aspect-ratio structures.

These advances open possibilities for non-contact electrical I&M during the front-end stages of semiconductor manufacturing—previously unattainable with conventional technologies—as well as defect and structural I&M deep inside high-aspect-ratio features, both of which could improve semiconductor manufacturing yield.

KIOXIA Iwate will begin evaluating the technology in its production lines to verify its impact on defect detection, yield improvement, and root cause analysis. This initiative is gaining attention as a model for implementing university-originated technologies and marks a concrete step toward semiconductor manufacturing innovation through collaboration between a university startup and a major corporation.

GaN photocathodes achieve industrial breakthrough

The potential value of photoelectron beam technology from semiconductor photocathodes for semiconductor manufacturing I&M has been recognized for more than a quarter of a century, yet its industrial application has been limited by issues of fragility. To overcome this barrier, researchers at Nagoya University developed GaN photocathodes, achieving more than twenty-fold improvement in durability over conventional technologies and realizing a breakthrough toward electron beam (e-beam) innovation that had been sought after for nearly five decades.

Further advances were achieved by PeS, which developed a type of electron gun specialized for GaN photocathodes. These electron guns demonstrated the lifetimes and uptime stability necessary for semiconductor manufacturing environment, thereby reinforcing the industrial viability of GaN photocathodes. Moreover, PeS has focused on pulsed e-beams and invented Digital Selective e-Beaming (DSeB), a technique that synchronizes e-beam scanning in scanning electron microscopy (SEM)—widely used for semiconductor I&M—with the laser irradiating the photocathode. This innovation enables the delivery of e-beams with controlled intensity to arbitrary pixel-level locations within SEM images, opening new possibilities for selective e-beam irradiation in semiconductor I&M.

An innovative approach to semiconductor inspection and metrology

While process technologies for device miniaturization and 3D integration are well established, I&M technologies began to reach critical limitations without any solutions in sight for solving yield issues. However, PeS has successfully demonstrated the effectiveness of a new I&M approach that addresses the following two challenges in semiconductor manufacturing:

Electrical I&M of nanoscale transistors: In semiconductor chips consisting of densely integrated nanoscale transistors, it is extremely difficult to perform electrical testing of individual transistors by conventional contact-probing. Using Digital Selective e-Beaming (DSeB), specific regions of nanoscale transistors within memory devices were selectively irradiated with the e-beam. By exploiting electron-beam–induced charging to generate gate bias (non-contact switching), PeS observed this electrical behavior in SEM images. I&M of 3D semiconductor devices with high aspect ratios: In advanced devices such as 2.5D and 3D chiplets, high-aspect-ratio trench structures with submicron openings are introduced. This makes it challenging to inspect and measure sidewalls, bottom structures, and defects. For deep observation of high-aspect-ratio silicon trenches, DSeB was used to selectively target the trench bottoms, enabling the detection of residues and visualization of bottom structures. These achievements open new possibilities not only for non-contact electrical I&M during the front-end stages of semiconductor manufacturing—previously unattainable with conventional technologies—but also for defect and structural I&M in deep high-aspect-ratio regions. Accordingly, this project is expected to provide a novel solution to persistent yield challenges in semiconductor device fabrication.

Significance and outlook

Based on these demonstrations, KIOXIA Iwate will begin evaluating the technology in its production lines with the goal of making it a core technology for future semiconductor manufacturing. The company will conduct detailed evaluations in actual production processes to determine its impact on yield improvement through enhanced defect detection and root cause analysis.

This initiative is also recognized as a model for the societal implementation of university-derived technologies, marking a concrete step toward innovation in semiconductor manufacturing through collaboration between a university startup and a major corporation.

END


ELSE PRESS RELEASES FROM THIS DATE:

Circle versus rectangle: Finding ‘Earth 2.0’ may be easier using a new telescope shape

2025-09-01
by Prof Heidi Newberg The Earth supports the only known life in the universe, all of it depending heavily on the presence of liquid water to facilitate chemical reactions. While single-celled life has existed almost as long as the Earth itself, it took roughly three billion years for multicellular life to form. Human life has existed for less than one 10 thousandth of the age of the Earth. All of this suggests that life might be common on planets that support liquid water, but it might be uncommon to find life that studies the universe and seeks to travel ...

Metformin changes blood metal levels in humans

2025-09-01
The widely used diabetes drug metformin changes blood metal levels in humans. The Kobe University study is an important step in understanding the drug’s many actions and designing better ones in the future. Metformin is the most widely prescribed diabetes drug in the world. Apart from lowering blood sugar levels, it is also known to have a broad range of beneficial side effects such as against tumors, inflammations and atherosclerosis. However, although it has been used for more than 60 years ...

Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation

2025-08-31
About The Study: Among patients without documented atrial arrhythmia recurrence after catheter ablation for atrial fibrillation, discontinuing oral anticoagulant therapy resulted in a lower risk for the composite outcome of stroke, systemic embolism, and major bleeding vs continuing direct oral anticoagulant therapy.  Corresponding Author: To contact the corresponding author, Boyoung Joung, MD, email cby6908@yuhs.ac. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ Editor’s Note: Please see the article for additional information, including other authors, author contributions and ...

Fractional flow reserve–guided complete vs culprit-only revascularization in non–ST-elevation myocardial infarction and multivessel disease

2025-08-31
About The Study: Fractional flow reserve-guided complete revascularization during the index procedure resulted in a significant reduction in the composite of all-cause death, nonfatal myocardial infarction, any revascularization, and stroke at 1 year. This was mainly driven by reduced repeat revascularization.  Corresponding Author: To contact the corresponding author, Tobias F. S. Pustjens, MD, email t.pustjens@gmail.com. To access the embargoed study: Visit our For The Media website at this link ...

Participation of women in cardiovascular trials from 2017 to 2023

2025-08-31
About The Study: The findings of this study highlight both progress and persistent challenges in representation of women within cardiovascular trials. These gaps not only limit the generalizability of trial outcomes but also perpetuate inequities in evidence-based care for women with cardiovascular conditions.  Corresponding Author: To contact the corresponding author, Martha Gulati, MD, MS, email martha.gulati@csmc.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ Editor’s Note: Please see the article for ...

Semaglutide and tirzepatide in patients with heart failure with preserved ejection fraction

2025-08-31
About The Study: In patients with cardiometabolic heart failure with preserved ejection fraction, semaglutide and tirzepatide showed more than 40% risk reduction for the composite of hospitalization for heart failure or all-cause mortality compared with a placebo proxy. Tirzepatide showed no meaningful benefit over semaglutide. Corresponding Author: To contact the corresponding author, Nils Krüger, MD, email nkruger1@bwh.harvard.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ Editor’s Note: Please ...

Changes in biology of internal fat may be the leading cause of heart failure

2025-08-31
Heart failure with preserved ejection fraction (HFpEF) appears to develop as a result of changes in the biology of a person’s internal fat tissue, according to the Adipokine Hypothesis, a new way of understanding how fat may impact the heart. The hypothesis paper was published today in JACC, the flagship journal of the American College of Cardiology, and is being presented at ESC Congress 2025. The author of the paper is Milton Packer, MD, FACC, Distinguished Scholar in Cardiovascular Science at Baylor University Medical Center at Dallas and Visiting Professor at Imperial College in London. “Up ...

Transcatheter or surgical treatment of patients with aortic stenosis at low to intermediate risk

2025-08-30
About The Study: In this individual participant data meta-analysis of 4 randomized clinical trials (RCTs), and an overall meta-analysis of 8 RCTs of patients with severe symptomatic aortic stenosis at low to intermediate risk, transcatheter aortic valve implantation (TAVI) was associated with a reduction in the 1-year incidence of all-cause death or any stroke. These findings emphasize TAVI as alternative option in patients at low to intermediate risk. Long-term follow-up is warranted to evaluate sustainability of these findings. Corresponding Authors: To contact the corresponding authors, email Moritz Seiffert, MD, (moritz.seiffert@bergmannsheil.de) and ...

Promising new drug for people with stubborn high blood pressure

2025-08-30
A new treatment has been shown to significantly lower blood pressure in people whose levels stay dangerously high, despite taking several existing medicines, according to the results of a Phase III clinical trial led by a UCL Professor. Globally around 1.3 billion people have high blood pressure (hypertension), and in around half of cases the condition is uncontrolled or treatment resistant. These individuals face a much greater risk of heart attack, stroke, kidney disease, and early death. In the UK the number of people with hypertension is around 14 ...

One shot of RSV vaccine effective against hospitalization in older adults for two seasons

2025-08-30
One shot of an RSV vaccine protects adults ages 60 or older from RSV-associated hospitalization and critical illness during two consecutive RSV seasons, according to a study published in JAMA today by the IVY Network research group. RSV causes substantial seasonal illness during fall and winter in the U.S., with an estimated 100,000-150,000 hospitalizations and 4,000-8,000 deaths occurring annually among adults 60 or older. The results reinforce the recommendations for RSV vaccines in older adults and lay the groundwork for understanding how long a single dose of the vaccine may be effective, ...

LAST 30 PRESS RELEASES:

Helicobacter pylori screening after acute myocardial infarction

Solar Orbiter traces superfast electrons back to Sun

GaN-based electron beam technology from Nagoya University startup poised to overcome critical semiconductor manufacturing challenges at KIOXIA

Circle versus rectangle: Finding ‘Earth 2.0’ may be easier using a new telescope shape

Metformin changes blood metal levels in humans

Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation

Fractional flow reserve–guided complete vs culprit-only revascularization in non–ST-elevation myocardial infarction and multivessel disease

Participation of women in cardiovascular trials from 2017 to 2023

Semaglutide and tirzepatide in patients with heart failure with preserved ejection fraction

Changes in biology of internal fat may be the leading cause of heart failure

Transcatheter or surgical treatment of patients with aortic stenosis at low to intermediate risk

Promising new drug for people with stubborn high blood pressure

One shot of RSV vaccine effective against hospitalization in older adults for two seasons

Bivalent RSV prefusion F protein–based vaccine for preventing cardiovascular hospitalizations in older adults

Clonal hematopoiesis and risk of new-onset myocarditis and pericarditis

Risk of myocarditis or pericarditis with high-dose vs standard-dose influenza vaccine

High-dose vs standard-dose influenza vaccine and cardiovascular outcomes in older adults

Prevalence, determinants, and time trends of cardiovascular health in the WHO African region

New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers

CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients

Systolic blood pressure and microaxial flow pump–associated survival in infarct-related cardiogenic shock

Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes

High Mountain Asia’s shrinking glaciers linked to monsoon changes

All DRII-ed up: How do plants recover after drought?

Research on stigma says to just ‘shake it off’

Scientists track lightning “pollution” in real time using NASA satellite

Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy

Hot days make for icy weather, Philippine study finds

Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology

World's first clinical trial showing lubiprostone aids kidney function

[Press-News.org] GaN-based electron beam technology from Nagoya University startup poised to overcome critical semiconductor manufacturing challenges at KIOXIA
New platform for semiconductor inspection and metrology developed through joint research by Photo electron Soul and Nagoya University begins validation at KIOXIA Iwate